The global influenza diagnostics market is poised for steady growth, driven by increasing awareness of infectious diseases, rising demand for rapid and accurate testing, and advancements in diagnostic technologies. Valued at USD 1.3 billion in 2022, the market is projected to surpass USD 2.0 billion by the end of 2031, expanding at a CAGR of 5.6% from 2023 to 2031. Factors such as seasonal influenza outbreaks, growing healthcare infrastructure, and the integration of point-of-care testing solutions are expected to further support market expansion over the forecast period.

Increase in prevalence and incidence of influenza is driving the global influenza diagnostics market. Persistent threat of seasonal and pandemic influenza outbreaks have been witnessed in the past few years. The global impact of influenza on public health has prompted substantial investments in research & development. Government initiatives aimed at influenza surveillance and outbreak control are the major factors propelling market development. Furthermore, rise in demand for rapid diagnostic tests is expected to bolster the global influenza diagnostics industry size during the forecast period.

Dive Deeper into Data: Get Your In-Depth Sample Now! https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=17435

Technological advancements and introduction of innovative diagnostic tools offer lucrative opportunities to market players. Manufacturers are focusing on developing user-friendly, portable, and cost-effective diagnostic devices in order to increase market share.

Key Findings of the Market Report

• Based on test type, Rapid Influenza Detection Tests (RIDTs) contribute the largest volume (31% share), while RT-PCR leads in revenue value due to higher unit costs.
• Hospitals remain the primary end-user segment (48% share), although Pharmacies and Urgent Care Centers are the fastest-growing channels for rapid screening.
• Molecular Diagnostics have surpassed traditional viral cultures in clinical preference, now accounting for nearly half of the total market revenue.
• The Type A Influenza segment holds a higher market share compared to Type B, due to its higher frequency and potential for pandemic outbreaks.

Global Market: Growth Drivers

• Shift to Point-of-Care (POC): Demand for results in under 20 minutes is pushing diagnostic volume into clinics and pharmacies.
• Rising Surveillance Initiatives: Government programs (like the WHO’s South-East Asia multi-country initiative) are expanding molecular diagnostic capabilities globally.
• Aging Population Susceptibility: The geriatric demographic remains a high-volume consumer for diagnostics due to the increased risk of severe flu complications.
• Consumerization of Health: The success of COVID-19 home testing has permanently altered consumer behavior, creating a viable market for OTC flu kits.

Buy this Premium Research Report:  https://www.transparencymarketresearch.com/checkout.php?rep_id=17435&ltype=S

Global Market: Key Players

Top-tier diagnostic firms are currently focused on "syndromic testing"—developing single swabs that can identify over 10 different respiratory pathogens at once.

• F. Hoffmann-La Roche Ltd (21% market share)
• Becton, Dickinson and Company (BD) (17% market share)
• Abbott Laboratories (ID NOW™ platform)
• Thermo Fisher Scientific Inc.
• QuidelOrtho Corporation
• bioMérieux SA
• Danaher Corporation (Cepheid)
• Hologic, Inc.
• Sekisui Diagnostics
• GenMark Diagnostics, Inc.

Global Market: Segmentation

By Test Type

• Molecular Diagnostics (RT-PCR, INAAT, LAMP)
• Rapid Influenza Detection Tests (RIDTs / Lateral Flow)
• Immunofluorescence Assays
• Viral Culture & Serology (Surveillance use)

By End-Use

• Hospitals & Clinical Labs
• Diagnostic Centers
• Pharmacies & Retail Clinics
• Research & Academic Institutes

By Type of Flu

• Influenza Type A
• Influenza Type B
• Influenza Type C

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com 
Sales Inquiries: sales@transparencymarketresearch.com
Media Inquiries: media@transparencymarketresearch.com